CorVista System with PH Add-On vs PMcardio
AI Verdict
Choose CorVista System with PH Add-On if…
Choose CorVista System with PH Add-On if you need a non-invasive, point-of-care diagnostic tool for rapid assessment of both coronary artery disease and pulmonary hypertension. This system is ideal for clinicians seeking to evaluate symptomatic patients for multiple cardiovascular conditions in a single visit, without the need for radiation, contrast agents, injections, fasting, or exercise. It's particularly useful when traditional methods like echocardiography may fail to raise suspicion for PH, enabling earlier detection and potentially reducing diagnostic delays.
View CorVista System with PH Add-On →Choose PMcardio if…
Choose PMcardio if you require an AI-powered platform for rapid and accurate interpretation of 12-lead ECGs to assess over 50 cardiac conditions. This tool is best suited for healthcare professionals who need instant, expert-level ECG interpretations at the point of care, including in emergency settings or primary care, to aid in confident clinical decision-making and reduce treatment delays. Its mobile app deployment and freemium model also make it accessible for individual clinicians and for bridging skills gaps in ECG interpretation.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CorVista System with PH Add-On | PMcardio |
|---|---|---|
| Pricing | Contact for pricing | Freemium |
| Deployment | Cloud-based (data collected at point-of-care, processed in the cloud, results via secure web portal). | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| FDA Status | 1 AI-estimated | Pending AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers deployment via a mobile app and web platform, allowing for immediate use without complex IT integration. Its ability to digitize any 12-lead ECG from an image, even if old or distorted, enhances its flexibility and ease of use in various clinical settings. CorVista System, while point-of-care, relies on a dedicated capture device and cloud processing, which might introduce more steps than PMcardio's direct image capture.
Clinical Value
PMcardioPMcardio is clinically validated in over 25 studies and detects more than 50 cardiac conditions, including STEMI/OMI with higher sensitivity than standard methods and reduced false positives. It also provides AI explainability with heatmaps (ECGxplainu2122) and patient management recommendations based on ESC guidelines. CorVista System is FDA-cleared for CAD and PH, with strong sensitivity and specificity in its validation studies, but PMcardio's broader range of detected conditions and extensive validation give it an edge.
Pricing & Value
PMcardioPMcardio offers a transparent freemium model with a free plan for individuals (5 ECG analyses/month) and clearly outlined subscription tiers for Pro, Teams, and Organizations. CorVista System's pricing is available only upon contact, making it less transparent for potential users. PMcardio's freemium model allows clinicians to experience its value before committing financially.
Enterprise Readiness
PMcardioPMcardio is designed for enterprise deployment with integrations for EHR/CVIS and EMS systems, offering a unified cardiac AI platform for multi-pathway, multi-site cardiac care. It boasts SOC 2 Type II, ISO 27001, GDPR, and HIPAA compliance, with regional data residency options. While CorVista System is cloud-based and likely HIPAA compliant, PMcardio explicitly details its enterprise-grade security, compliance, and integration capabilities.
Innovation
PMcardioPMcardio demonstrates strong innovation with its 'Queen of Hearts' AI for STEMI/OMI detection, which has shown superior accuracy and reduced false activations compared to standard methods. Its 'ECGxplainu2122' feature provides visual AI explainability, enhancing trust and understanding. CorVista System's non-invasive, point-of-care approach for CAD and PH is innovative, particularly its breakthrough device designation for PH, but PMcardio's continuous development of new AI modules and explainability features show a broader innovative scope.
Support & Docs
PMcardioPMcardio provides a comprehensive Help Center with user-friendly tutorials, manuals, FAQs, and detailed regulatory and security documentation. It also offers resources like a blog and research publications. CorVista System's documentation and support resources are not explicitly detailed in the provided information, making PMcardio's offerings appear more robust and accessible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CorVista System with PH Add-On | PMcardio |
|---|---|---|
| Name | CorVista System with PH Add-On | PMcardio |
| Company | Analytics for Life | Powerful Medical |
| Description | The CorVista System with PH Add-On is an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms. | PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care. |
| Key Features | Non-invasive cardiovascular diagnostics, Point-of-care testing, Machine-learned algorithms for analysis, Analyzes cardiac and hemodynamic signals, No radiation, contrast agents, injections, fasting, or exercise required, Rapid results available within minutes, Secure web portal for physician access to analysis, Modular design with disease-specific add-ons (CAD, PH) | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference |
Videos
Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and PMcardio.